BRPI0811431A2 - Composição farmacêutica aquosa. - Google Patents
Composição farmacêutica aquosa.Info
- Publication number
- BRPI0811431A2 BRPI0811431A2 BRPI0811431-5A BRPI0811431A BRPI0811431A2 BR PI0811431 A2 BRPI0811431 A2 BR PI0811431A2 BR PI0811431 A BRPI0811431 A BR PI0811431A BR PI0811431 A2 BRPI0811431 A2 BR PI0811431A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- aqueous pharmaceutical
- aqueous
- composition
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007021862A DE102007021862A1 (de) | 2007-05-10 | 2007-05-10 | Wässrige pharmazeutische Zubereitung |
PCT/EP2008/003291 WO2008138459A2 (de) | 2007-05-10 | 2008-04-24 | Wässrige pharmazeutische zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0811431A2 true BRPI0811431A2 (pt) | 2015-06-16 |
Family
ID=39537491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0811431-5A BRPI0811431A2 (pt) | 2007-05-10 | 2008-04-24 | Composição farmacêutica aquosa. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100210681A1 (pt) |
EP (1) | EP2142169B1 (pt) |
JP (1) | JP2010526783A (pt) |
KR (1) | KR20100029758A (pt) |
CN (1) | CN101677941A (pt) |
AR (1) | AR066504A1 (pt) |
AT (1) | ATE530164T1 (pt) |
AU (1) | AU2008250717A1 (pt) |
BR (1) | BRPI0811431A2 (pt) |
CA (1) | CA2686765A1 (pt) |
CL (1) | CL2008001384A1 (pt) |
CO (1) | CO6220901A2 (pt) |
DE (1) | DE102007021862A1 (pt) |
EA (1) | EA200901498A1 (pt) |
EC (1) | ECSP099788A (pt) |
IL (1) | IL201912A0 (pt) |
MX (1) | MX2009012035A (pt) |
PE (1) | PE20090246A1 (pt) |
TW (1) | TW200911252A (pt) |
WO (1) | WO2008138459A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
US20130029919A1 (en) | 2011-07-26 | 2013-01-31 | Allergan, Inc. | Two part formulation system for opthalmic delivery |
KR102126727B1 (ko) | 2018-03-29 | 2020-07-07 | 이혜영 | 자동차 표면 광택방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2033959T3 (pl) * | 2003-12-20 | 2011-09-30 | Merck Patent Gmbh | Pochodne tetrahydropiranochinolinowe |
US7361683B2 (en) * | 2004-11-24 | 2008-04-22 | Yung Shin Pharm. Ind., Co., Ltd | Paclitaxel aqueous injection solution and methods for preparing the same |
EP2032581B1 (en) * | 2006-06-19 | 2015-03-11 | Merck Patent GmbH | Enantiomerically enriched compounds and process |
-
2007
- 2007-05-10 DE DE102007021862A patent/DE102007021862A1/de not_active Withdrawn
-
2008
- 2008-04-24 CA CA002686765A patent/CA2686765A1/en not_active Abandoned
- 2008-04-24 EA EA200901498A patent/EA200901498A1/ru unknown
- 2008-04-24 JP JP2010506818A patent/JP2010526783A/ja not_active Abandoned
- 2008-04-24 MX MX2009012035A patent/MX2009012035A/es active IP Right Grant
- 2008-04-24 WO PCT/EP2008/003291 patent/WO2008138459A2/de active Application Filing
- 2008-04-24 AU AU2008250717A patent/AU2008250717A1/en not_active Abandoned
- 2008-04-24 CN CN200880015535A patent/CN101677941A/zh active Pending
- 2008-04-24 AT AT08749090T patent/ATE530164T1/de active
- 2008-04-24 BR BRPI0811431-5A patent/BRPI0811431A2/pt not_active IP Right Cessation
- 2008-04-24 EP EP08749090A patent/EP2142169B1/de not_active Not-in-force
- 2008-04-24 US US12/599,427 patent/US20100210681A1/en not_active Abandoned
- 2008-04-24 KR KR1020097025713A patent/KR20100029758A/ko not_active Application Discontinuation
- 2008-05-08 PE PE2008000805A patent/PE20090246A1/es not_active Application Discontinuation
- 2008-05-09 CL CL2008001384A patent/CL2008001384A1/es unknown
- 2008-05-09 TW TW097117319A patent/TW200911252A/zh unknown
- 2008-05-09 AR ARP080101966A patent/AR066504A1/es unknown
-
2009
- 2009-09-25 CO CO09105019A patent/CO6220901A2/es not_active Application Discontinuation
- 2009-11-03 IL IL201912A patent/IL201912A0/en unknown
- 2009-12-08 EC EC2009009788A patent/ECSP099788A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO6220901A2 (es) | 2010-11-19 |
ATE530164T1 (de) | 2011-11-15 |
ECSP099788A (es) | 2010-01-29 |
KR20100029758A (ko) | 2010-03-17 |
WO2008138459A3 (de) | 2009-06-04 |
US20100210681A1 (en) | 2010-08-19 |
AU2008250717A1 (en) | 2008-11-20 |
CA2686765A1 (en) | 2008-11-20 |
JP2010526783A (ja) | 2010-08-05 |
TW200911252A (en) | 2009-03-16 |
CN101677941A (zh) | 2010-03-24 |
PE20090246A1 (es) | 2009-03-19 |
EA200901498A1 (ru) | 2010-04-30 |
DE102007021862A1 (de) | 2008-11-13 |
MX2009012035A (es) | 2009-11-18 |
EP2142169B1 (de) | 2011-10-26 |
WO2008138459A2 (de) | 2008-11-20 |
IL201912A0 (en) | 2010-06-16 |
AR066504A1 (es) | 2009-08-26 |
EP2142169A2 (de) | 2010-01-13 |
CL2008001384A1 (es) | 2009-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2140867I2 (lt) | Farmacinė kompozicija | |
BRPI1012892A2 (pt) | composto, e, composição farmacêutica. | |
BRPI0910503A2 (pt) | compostos, composições farmacêuticas e respectivos usos. | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
BRPI0812354A2 (pt) | Composição farmacêutica não-aquosa. | |
BRPI0920521A2 (pt) | combinação farmacêutica | |
FR2909857B1 (fr) | Endovalve. | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
BRPI1016190A2 (pt) | compostos farmacêuticos. | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
BRPI0917446A2 (pt) | derivados de acilaminobenzamida. | |
DK2193795T3 (da) | Latanoprostholdig vandig farmaceutisk sammensætning | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
BRPI0914182A2 (pt) | composto, e, composição farmacêutica | |
BRPI0912171A2 (pt) | composição farmacêutica | |
BRPI0816679A2 (pt) | Derivados de ftalazinona. | |
FR2923713B1 (fr) | Composition reductrice epaissie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |